articleThe Journal of ImmunologyAug 1, 2007BRONZE OA

Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice

University of California, San Francisco · Oaklands Hospital

PubMed
Indexed incrossrefpubmed

Abstract

Recent in vivo and in vitro work suggests that mesenchymal stem cells (MSC) have anti-inflammatory properties. In this study, we tested the effect of administering MSC directly into the airspaces of the lung 4 h after the intrapulmonary administration of Escherichia coli endotoxin (5 mg/kg). MSC increased survival compared with PBS-treated control mice at 48 h (80 vs 42%; p

Citation impact

955
total citations
FWCI
19.31
Percentile
100%
References
38
Citations per year

Authors

6

Topics & keywords

Keywords
  • Bronchoalveolar lavage
  • Mesenchymal stem cell
  • Medicine
  • Proinflammatory cytokine
  • Lung
  • Bone marrow
  • In vivo
  • Pulmonary edema
No related works found for this paper.